MedPath

se of paracetamol and paracetamol & dexmedetomidine combination for reduction of analgesic requirement and reduction of nausea and vomiting after operation in laparoscopic surgery.

Phase 4
Completed
Conditions
Health Condition 1: N859- Noninflammatory disorder of uterus, unspecifiedHealth Condition 2: N859- Noninflammatory disorder of uterus, unspecified
Registration Number
CTRI/2022/08/045086
Lead Sponsor
Apollo Hospitals Bilaspur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
104
Inclusion Criteria

1. ASA grade I and II

2. Scheduled for laparoscopic gynaecological surgery under general anesthesia

Exclusion Criteria

1.Known allergy to study drugs

2.Use of antiemetic drugs within 24 hrs of surgery

3.Morbid obesity(BMI >40)

4.Chronic use of opioids

5.Patients with hepatic,renal or cardiovascular dysfunction

6.Psychiatric patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath